AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gerald Batist, MD
Jewish General Hospital
Study Chair - Glenwood D. Goss, MD, BCh, FCP, FRCPC
Ottawa Regional Cancer Centre
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ottawa Hospital Regional Cancer Centre - General Campus
Ottawa, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Jewish General Hospital - Montreal
Montreal, Quebec, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Nov 2005
- Primary completion
- 18 Sept 2007
- Completion
- 22 Sept 2008
- Last update posted
- 4 Aug 2023
- Registered enrollment
- 31
- Registry id
- NCT00343408
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.